Origin, methods, and evolution of the three nurses' health studies

American Journal of Public Health

Volumn 106, Issue 9, 2016, Pages 1573-1581

  Bao, Ying ^a   Bertoia, Monica L ^b   Lenart, Elizabeth B ^b   Stampfer, Meir J ^a   Willett, Walter C ^b   Speizer, Frank E ^a   Chavarro, Jorge E ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; DEMOGRAPHY; EPIDEMIOLOGY; FEMALE; HUMAN; LONGITUDINAL STUDY; METHODOLOGY; MIDDLE AGED; NURSE; PROSPECTIVE STUDY; QUESTIONNAIRE; UNITED STATES; WOMEN'S HEALTH;

ADULT; DEMOGRAPHY; EPIDEMIOLOGIC STUDIES; FEMALE; HUMANS; LONGITUDINAL STUDIES; MIDDLE AGED; NURSES; PROSPECTIVE STUDIES; RESEARCH DESIGN; SURVEYS AND QUESTIONNAIRES; UNITED STATES; WOMEN'S HEALTH;

EID: 84982163151     PISSN: 00900036     EISSN: 15410048     Source Type: Journal    
DOI: 10.2105/AJPH.2016.303338     Document Type: Review

References (34)

1. Doll R, Hill AB. The mortality of doctors in relation to their smoking habits; a preliminary report. BMJ. 1954;1(4877): 1451-1455.
2. Salvini S, Hunter DJ, Sampson L, et al. Food-based validation of a dietary questionnaire: The effects of week- To-week variation in food consumption. Int J Epidemiol. 1989;18(4):858-867.
3. Brazier JE, Harper R, Jones NM, et al. Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ. 1992;305(6846): 160-164.
4. Michels KB, Willett WC, Graubard BI, et al. A longitudinal study of infant feeding and obesity throughout life course. Int J Obes (Lond). 2007;31(7):1078-1085.
5. Hu FB, Satija A, Rimm EB, et al. Diet assessment methods in the Nurses' Health Studies and contribution to evidence-based nutritional policies and guidelines. Am J Public Health. 2016;106(9):1567-1572.
6. Wolf AM, Hunter D, Colditz GA, et al. Reproducibility and validity of a selfadministered physical activity questionnaire. Int J Epidemiol. 1994;23(5):991-999.
7. Rimm EB, Stampfer MJ, Colditz GA, Giovannucci E, Willett WC.Effectiveness of various mailing strategies among nonrespondents in a prospective cohort study. Am J Epidemiol. 1990;131(6):1068-1071.
8. Colditz GA, Martin P, Stampfer MJ, et al. Validation of questionnaire information on risk factors and disease outcomes in a prospective cohort study of women. Am J Epidemiol. 1986;123(5): 894-900.
9. Rimm EB, Stampfer MJ, Colditz GA, Chute CG, Litin LB, Willett WC.Validity of self-reported waist and hip circumferences in men and women. Epidemiology. 1990;1(6):466-473.
10. Rich-Edwards JW, Corsano KA, Stampfer MJ. Test of the National Death Index and Equifax Nationwide Death Search. Am J Epidemiol. 1994;140(11): 1016-1019.
11. Hankinson SE, London SJ, Chute CG, et al. Effect of transport conditions on the stability of biochemical markers in blood. Clin Chem. 1989;35(12):2313-2316.
12. Schernhammer ES, Hankinson SE. Urinary melatonin levels and breast cancer risk. J Natl Cancer Inst. 2005;97(14): 1084-1087.
13. Camp RL, Charette LA, Rimm DL. Validation of tissue microarray technology in breast carcinoma. Lab Invest. 2000; 80(12):1943-1949.
14. Collins LC, Cole KS, Marotti JD, Hu R, Schnitt SJ, Tamimi RM. Androgen receptor expression in breast cancer in relation to molecular phenotype: Results from the Nurses' Health Study. Mod Pathol. 2011;24(7):924-931.
15. Collins LC, Marotti JD, Baer HJ, Tamimi RM. Comparison of estrogen receptor results from pathology reports with results from central laboratory testing. J Natl Cancer Inst. 2008;100(3): 218-221.
16. Holmes MD, Chen WY, Schnitt SJ, et al. COX-2 expression predicts worse breast cancer prognosis and does not modify the association with aspirin. Breast Cancer Res Treat. 2011;130(2):657-662.
17. Hu R, Dawood S, Holmes MD, et al. Androgen receptor expression and breast cancer survival in postmenopausal women. Clin Cancer Res. 2011;17(7): 1867-1874.
18. Liu Y, Tamimi RM, Collins LC, et al. The association between vascular endothelial growth factor expression in invasive breast cancer and survival varies with intrinsic subtypes and use of adjuvant systemic therapy: Results from the Nurses' Health Study. Breast Cancer Res Treat. 2011;129(1):175-184.
19. Santagata S, Hu R, Lin NU, et al. High levels of nuclear heat-shock factor 1 (HSF1) are associated with poor prognosis in breast cancer. Proc Natl Acad Sci USA. 2011;108(45):18378-18383.
20. Tamimi RM, Baer HJ, Marotti J, et al. Comparison of molecular phenotypes of ductal carcinoma in situ and invasive breast cancer. Breast Cancer Res. 2008;10(4):R67.
21. Ogino S, Chan AT, Fuchs CS, Giovannucci E. Molecular pathological epidemiology of colorectal neoplasia: An emerging transdisciplinary and interdisciplinary field. Gut. 2011;60(3):397-411.
22. Ogino S, Stampfer M. Lifestyle factors and microsatellite instability in colorectal cancer: The evolving field of molecular pathological epidemiology. J Natl Cancer Inst. 2010;102(6):365-367.
23. Byrne C, Schairer C, Wolfe J, et al. Mammographic features and breast cancer risk: effects with time, age, and menopause status. J Natl Cancer Inst. 1995;87(21): 1622-1629.
24. Boyd NF, Lockwood GA, Martin LJ, Byng JW, Yaffe MJ, Tritchler DL. Mammographic density as a marker of susceptibility to breast cancer: A hypothesis. IARC Sci Publ. 2001;154:163-169.
25. Boyd NF, Martin LJ, Stone J, Greenberg C, Minkin S, Yaffe MJ. Mammographic densities as a marker of human breast cancer risk and their use in chemoprevention. Curr Oncol Rep. 2001; 3(4):314-321.
26. Tamimi RM, Hankinson SE, Colditz GA, Byrne C. Endogenous sex hormone levels and mammographic density among postmenopausal women. Cancer Epidemiol Biomarkers Prev. 2005;14(11 pt1): 2641-2647.
27. Tamimi RM, Byrne C, Colditz GA, Hankinson SE. Endogenous hormone levels, mammographic density, and subsequent risk of breast cancer in postmenopausal women. J Natl Cancer Inst. 2007;99(15):1178-1187.
28. Liao X, Zucker DM, Li Y, Spiegelman D. Survival analysis with error-prone time-varying covariates: A risk set calibration approach. Biometrics. 2011;67(1): 50-58.
29. Holmes MD, Chen WY, Feskanich D, Kroenke CH, Colditz GA. Physical activity and survival after breast cancer diagnosis. JAMA. 2005;293(20): 2479-2486.
30. Holmes MD, Chen WY, Li L, Hertzmark E, Spiegelman D, Hankinson SE. Aspirin intake and survival after breast cancer. J Clin Oncol. 2010;28(9): 1467-1472.
31. Chan AT, Ogino S, Fuchs CS. Aspirin use and survival after diagnosis of colorectal cancer. JAMA. 2009;302(6):649-658.
32. Townsend MK, Clish CB, Kraft P, et al. Reproducibility of metabolomic profiles among men and women in 2 large cohort studies. Clin Chem. 2013;59(11):1657-1667.
33. Mayers JR, Wu C, Clish CB, et al. Elevation of circulating branched-chain amino acids is an early event in human pancreatic adenocarcinoma development. Nat Med. 2014;20(10):1193-1198.
34. Colditz GA, Philpott SE, Hankinson SE. The impact of the Nurses' Health Study on population health: prevention, translation, and control. Am J Public Health. 2016;106(9):1540-1545.